Shanghai Biopharmaleader co.,ltd

If you are going to consult the information about 1350514-68-9 from one of the leading 1350514-68-9 manufacturers and suppliers in China,Website:://.biopharmaleader.net, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO.1350514-68-9 Product NameGrazoprevirSynonymsMK-5172FormulaC38H50N6O9SMolecular Weight766.9Spec / Purity98%minSupply CapacityDetailsGrazoprevir (MK-5172) is an experimental drug for the treatment of hepatitis C. It is currently in Phase III trials, following promising results in Phase II when used in combination with the NS5A replication complex inhibitor elbasvir, either with or without ribavirin. Grazoprevir is a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets. It has good activity against a range of HCV genotype variants, including some that are resistant to most currently used antiviral medications.